Cipla Limited

NSE: CIPLA

Pharma Pharmaceuticals

₹1,324.1

-0.08%EOD · 19 Oct

Mumbai-based generics company known for humanitarian pricing — first to offer antiretroviral HIV drugs at 1% of Western cost. Strong in respiratory, anti-infectives, and oncology.

Market Cap

₹1.07 L Cr

52W Range

₹1673 / ₹1166

Volume

1387K

68.6% delivery

1Y Return

-15.1%

P/E Ratio

31.8

P/B Ratio

3.1

ROE

11.7%

Debt / Equity

1.78

Peers in Pharma

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Cipla Limited(this stock)	₹1,324.1	₹1.07 L Cr	31.8	3.1	11.7%	0.98%
Sun Pharmaceutical Industries LimitedSUNPHARMA	₹1,743	₹4.18 L Cr	34.9	5.0	14.7%	0.91%
Dr. Reddy's Laboratories LimitedDRREDDY	₹1,242.5	₹1.03 L Cr	31.0	2.7	8.8%	0.66%
Lupin LimitedLUPIN	₹1,939.2	₹88,678 Cr	16.3	4.0	26.9%	0.91%

Quality Score

Durability · Valuation · Momentum — objective math, not advice

40/100

Composite score: 40% quality, 30% valuation, 30% momentum

QualityGood · 58

ValuationAverage · 45

MomentumPoor · 10

In confirmed downtrend (Stage 4)

Technical Indicators

Full analysis · objective math, not advice

Returns

-0.1%

+1.0%

-5.0%

-6.4%

+7.1%

-15.1%

Weinstein Stage

Stage 4 — Declining (downtrend)

RSI (14)

31 Neutral

Trend Template

3/7weak

RS vs Nifty (3M)

-0.4pp

Moving Averages (price vs MA)

20-DMA

₹1345

below

50-DMA

₹1383

below

150-DMA

₹1370

below

200-DMA

₹1369

below

From 52W High

-20.9%

From 52W Low

+13.6%

Support (20D)

₹1292

Resistance (20D)

₹1421

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+5.9% CAGR

Up 7 of last 11 years

Earnings Quality

Mostly cash-backed

OCF / Net Profit = 0.81x · 12/12 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.